相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。STAT1 signaling in CD8 T cells is required for their clonal expansion and memory formation following viral infection in vivo
Michael Quigley et al.
JOURNAL OF IMMUNOLOGY (2008)
Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection
Jacopo Mariotti et al.
JOURNAL OF IMMUNOLOGY (2008)
Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells
Jun Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival
Hans Hoelschermann et al.
CARDIOVASCULAR RESEARCH (2006)
Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism
JE Foley et al.
JOURNAL OF IMMUNOLOGY (2005)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation
AM Hanash et al.
BLOOD (2005)
Co-stimulated/Tc2 cells abrogate murine marrow graft rejection
AA Erdmann et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
PA Taylor et al.
BLOOD (2004)
Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells
S Reich-Zeliger et al.
JOURNAL OF IMMUNOLOGY (2004)
Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis
S Reich-Zeliger et al.
JOURNAL OF IMMUNOLOGY (2004)
Conditional deletion of Gata3 shows its essential function in TH1-TH2 responses
JF Zhu et al.
NATURE IMMUNOLOGY (2004)
Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose
E Bachar-Lustig et al.
BLOOD (2003)
Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-Bet through activation of STAT1 during initial Th1 commitment
A Takeda et al.
JOURNAL OF IMMUNOLOGY (2003)
CW/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects
U Jung et al.
BLOOD (2003)
Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion
M Higuchi et al.
JOURNAL OF IMMUNOLOGY (2002)
Tolerance induction by megadose hematopoietic progenitor cells:: expansion of veto cells by short-term culture of purified human CD34+ cells
H Gur et al.
BLOOD (2002)
T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells
M Afkarian et al.
NATURE IMMUNOLOGY (2002)
Anti-third party CD8+ CTLs as potent veto cells:: Coexpression of CD8 and FasL is a prerequisite
S Reich-Zeliger et al.
IMMUNITY (2000)
A novel transcription factor, T-bet, directs Th1 lineage commitment
SJ Szabo et al.
CELL (2000)